4//SEC Filing
Gilmour Duncan 4
Accession 0001062993-25-007444
CIK 0001036262other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:31 PM ET
Size
13.4 KB
Accession
0001062993-25-007444
Insider Transaction Report
Form 4
INTEST CORPINTT
Gilmour Duncan
CFO, Treasurer & Secretary
Transactions
- Disposition to Issuer
Common Stock
2025-04-14−6,831→ 61,104 total
Holdings
- 18,077
Employee Stock Option (right to buy)
Exercise: $7.74Exp: 2035-03-16→ Common Stock (18,077 underlying) - 8,104
Employee Stock Option (right to buy)
Exercise: $16.80Exp: 2031-06-13→ Common Stock (8,104 underlying) - 12,724
Employee Stock Option (right to buy)
Exercise: $11.33Exp: 2034-03-05→ Common Stock (12,724 underlying) - 200(indirect: By Spouse)
Common stock
- 8,044
Employee Stock Option (right to buy)
Exercise: $16.06Exp: 2033-03-07→ Common Stock (8,044 underlying) - 12,848
Employee Stock Option (right to buy)
Exercise: $9.76Exp: 2032-03-08→ Common Stock (12,848 underlying) - 1,992
Employee Stock Option (right to buy)
Exercise: $7.74Exp: 2035-03-16→ Common Stock (1,992 underlying)
Footnotes (7)
- [F1]Shares forfeited under the terms of Mr. Gilmour's performance-based restricted stock award granted on March 9, 2022.
- [F2]This option vests in four equal annual installments commencing on March 17, 2026.
- [F3]This option vests in four equal annual installments commencing on March 17, 2026.
- [F4]This option vests in four equal annual installments commencing on March 6, 2025.
- [F5]This option vests in four equal annual installments commencing on March 8, 2024.
- [F6]This option vests in four equal annual installments commencing on March 9, 2023.
- [F7]This option vests in four equal annual installments commencing on June 14, 2022.
Issuer
INTEST CORP
CIK 0001036262
Entity typeother
Related Parties
1- filerCIK 0001866719
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 4:31 PM ET
- Size
- 13.4 KB